Eli Lilly Starts Clinical Testing Of Coronavirus COVID-19 Therapies Baricitinib, LY3127804

Baricitinib Research Commences in NIH-led Adaptive Coronavirus COVID-19 Treatment Trial. Eli Lilly Starts Phase 2 Trial with Anti-Ang2 in Coronavirus COVID-19 Indianapolis – On April 10th, 2020, Eli Lilly and … Read More

Oakland News Now

Zennie62Media, Inc., Legal Notice: You cannot copy content of this page